Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Market Capitalization: 37.46 B
The data is delayed by 15 minutes.
BDX is in the long-term up 234% in 11 years.
Description: Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company?s BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; and generic prefilled injectables. Its BD Diagnostics segment provides products for the collection and transportation of diagnostics specimens; and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections, and cancers. This segment?s products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood and tuberculosis culturing systems; molecular testing systems; microorganism identification and
|Shares Outstanding||212.2 M||EPS||8.3||EPS Growth - 4 Quarters||-54.75%||EPS Growth - Q/Q||-16.67%|
|EPS Growth - Y/Y||-15.77%||Sales Growth - 4 Quarters||-4.96%||Sales Growth - Q/Q||0%||P/E||23.05|
|P/E To EPS Growth||-1.07||P/S||4.43||P/BV||5.23||Price/Cash Per Share||17.6|
|Price/Free Cash Flow||32.46||ROA||3.81%||ROE||15.07%||ROI||5.32%|
|Current Ratio||1.56||Quick Ratio||1.05||Long Term Debt/Equity||4.85||Debt Ratio||0.63|
|Gross Margin||50.87%||Operating Margin||17.6%||Net Profit Margin||12.75%||Dividend Payout Ratio||-40.96%|
|Cash From Financing Activities||7.39 B||Cash From Investing Activities||-7.83 B||Cash From Operating Activities||514 M||Gross Profit||1.05 B|
|Net Profit||216 M||Operating Profit||293 M||Total Assets||28.29 B||Total Current Assets||7 B|
|Total Current Liabilities||4.5 B||Total Debt||13.84 B||Total Liabilities||21.13 B||Total Revenue||2.05 B|
|High 52 week||263.51||Low 52 week||209.85||Last close||227.62||Last change||1.08%|
|RSI||37.42||Average true range||5.37||Beta||0.56||Volume||378.9 K|
|Simple moving average 20 days||-1.43%||Simple moving average 50 days||-5.15%||Simple moving average 200 days||-5.97%|
|Performance Week||1.31%||Performance Month||1.1%||Performance Quart||-7.76%||Performance Half||-2.62%|
|Performance Year||1.55%||Performance Year-to-date||1.02%||Volatility daily||1.29%||Volatility weekly||2.9%|
|Volatility monthly||5.93%||Volatility yearly||20.56%||Relative Volume||181.88%||Average Volume||1.33 M|
|New High||New Low|
2019-09-18 10:07:49 | Have Insiders Been Selling Becton, Dickinson and Company NYSE:BDX Shares This Year?
2019-09-11 09:10:01 | Cybersecurity a Top Priority for Healthcare: 3 Stocks to Watch
2019-09-05 09:31:01 | Why Is Becton Dickinson BDX Up 4.1% Since Last Earnings Report?
2019-08-31 09:58:10 | What Kind Of Shareholder Owns Most Becton, Dickinson and Company NYSE:BDX Stock?
2019-08-29 22:56:35 | Top 5 Recession Stocks
2019-08-29 16:31:06 | China Ups Tariffs On Medical Devices — Are These Stocks Sweating?
2019-08-27 09:13:00 | 3 Dividend Aristocrats to Buy and Hold Forever
2019-08-23 14:00:29 | 5 Healthcare Stocks to Buy for Healthy Dividends
2019-08-21 16:30:00 | BD to Present at Investor Healthcare Conferences
2019-08-20 14:28:06 | Top Analyst Reports for Estee Lauder, Becton, Dickinson & Applied Materials
2019-08-15 10:15:02 | FDA Resets PAD Guidelines: The Road Ahead for Device Makers
2019-08-15 09:44:01 | Cardiovascular Systems Set to Present LIBERTY 360 Outcome
2019-08-14 13:18:22 | A Look At The Intrinsic Value Of Becton, Dickinson and Company NYSE:BDX
2019-08-13 14:23:00 | Becton, Dickinson Accelerates Its Growth
2019-08-06 19:59:28 | Edited Transcript of BDX earnings conference call or presentation 6-Aug-19 12:00pm GMT
2019-08-06 16:23:41 | Becton Dickinson & Co. BDX Q3 2019 Earnings Call Transcript
2019-08-06 10:28:02 | China Arrests Yuan's Plunge. Will Markets Gain?
2019-08-06 10:07:02 | Stock Market News For Aug 6, 2019
2019-08-06 09:53:01 | Index Futures Rebound as China Arrests Yuan Plunge
2019-08-06 08:25:12 | Becton, Dickinson BDX Beats on Q3 Earnings and Revenues
2019-08-06 08:16:11 | Becton Dickinson Reports Mixed Q3 Earnings, Reaffirms Guidance
2019-08-06 07:30:11 | Becton Dickinson BDX Q3 Earnings and Revenues Top Estimates
2019-08-06 06:00:00 | BD Announces Results For 2019 Third Fiscal Quarter; Reaffirms Fiscal 2019 Guidance
2019-08-06 02:03:00 | Becton Dickinson Earnings Beat, Revenue Misses In Q3
2019-08-05 08:37:12 | Should You Buy Becton, Dickinson BDX Ahead of Earnings?
2019-08-01 19:20:48 | Acquisition Boosts Exact Sciences' Role in Cancer Diagnostics
2019-07-31 09:05:01 | Can BD Medical Drive Becton, Dickinson's BDX Q3 Earnings?
2019-07-31 05:10:48 | 10 Bargain Blue Chips Seen Surging As Fed Lowers Rates
2019-07-29 10:04:02 | What's in the Cards for DaVita DVA This Earnings Season?
2019-07-29 07:59:13 | Should We Be Cautious About Becton, Dickinson and Company's NYSE:BDX ROE Of 5.1%?
2019-07-27 12:17:00 | 10 Biggest Medical Device Stocks
2019-07-23 06:59:00 | BD releases 2018 Sustainability Report
2019-07-22 17:11:00 | BD Board Declares Dividends
2019-07-18 09:19:01 | IVD Market Sustains Momentum: 3 Stocks in Focus
2019-07-02 16:15:00 | BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
2019-06-26 08:00:00 | A Mutual-Fund Fixer Designs His Own Fund, With Flexibility in Mind
2019-06-20 17:45:00 | BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices
2019-06-20 15:03:07 | Top Research Reports for Adobe, Charter Communications & HCA Healthcare
2019-06-18 08:05:12 | Merit Medical Acquires Brightwater Medical for $35 Million
2019-06-18 08:00:28 | See what the IHS Markit Score report has to say about Becton Dickinson and Co.